Hui Shao
Commercial Aircraft Corporation of China (China)(CN)Joint Institute for Laboratory Astrophysics(US)Emory University(US)Shanghai Jiao Tong University(CN)Yantai University(CN)Chinese Academy of Sciences(CN)University Corporation for Atmospheric Research(US)University Corporation for Atmospheric Research(US)Jiangxi University of Technology(CN)University of Florida(US)Suzhou Institute of Nano-tech and Nano-bionics(CN)Zhuhai People's Hospital(CN)Shaoxing City Women and Children Hospital(CN)Woodruff Health Sciences Center(US)Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine(CN)Ninghai County First Hospital(CN)Georgia Department of Public Health(US)Group for the Analysis of Development(PE)Beijing Tsinghua Chang Gung Hospital(CN)Affiliated Hospital of Jining Medical University(CN)University of Glasgow(GB)University of Guelph(CA)Tsinghua University(CN)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Health Systems, Economic Evaluations, Quality of Life, Chronic Disease Management Strategies, Medication Adherence and Compliance
Most-Cited Works
- → Bridging Research to Operations Transitions: Status and Plans of Community GSI(2015)118 cited
- → Newer glucose‐lowering drugs and risk of dementia: A systematic review and meta‐analysis of observational studies(2023)92 cited
- → Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO)(2018)86 cited
- → Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review(2017)78 cited
- → Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation(2019)77 cited
- → Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review